Advancing bio-printing of living cells for regenerative medicine
Europese Commissie
Biomedische onderzoekers en medische professionals die bio-printing willen gebruiken voor regeneratieve geneeskunde.
Ook bekend als HORIZON-HLTH-2027-03-TOOL-02, HORIZON-HLTH-2027-03, Cluster 1 - Health (Single stage - 2027/2)
Waar is deze subsidie voor?
Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to most of the following expected outcomes: Biomedical scientists from academia and industry will gain access to entire bio-printing units designed to regenerate human tissue. Healthcare professionals acquire information on the safe and effective use of equipment enabling advanced therapies with bio-printed human tissue. Healthcare providers dispose of tools enabling them to treat conditions of unmet medical need. Individual patients will benefit from a personalised approach to their respective medical condition thanks to the bio-printed regenerative medicine solution. Scope: Tissue-specific functional 3D bio-printing of living cells has made significant progress as a new approach for transplantation applications in regenerative medicine. There are currently several types of bio-printing technologies under development for the repair of different targeted tissues or organs. To fully unleash the potential of bio-printed cell constructs for regenerative medicine several bottlenecks still need to be overcome. Various studies in pre-clinical models have shown that bio-printed cell constructs or tissues hold great promise for r…
Voor wie is het bedoeld?
Biomedische onderzoekers en medische professionals die bio-printing willen gebruiken voor regeneratieve geneeskunde.
Waarvoor kunt u subsidie krijgen?
- Bio-printing weefselherstel
- Regeneratieve geneeskunde
- Biomedische innovatie
- Gepersonaliseerde medische behandeling
Kom ik in aanmerking?
De eisen uit de regeling. Uw situatie bepaalt of u voldoet; dit is geen beschikking.
Openstellingen en rondes
- Start
- 3 jun 2027
- Sluit
- 22 sep 2027
- Budget
- -
- Verdeling
- Tender
Bronnen en actualiteit
“Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver res…”
Geen openbare bronnen beschikbaar.
Deze informatie is geautomatiseerd samengesteld uit officiële bronnen en kan onvolledig zijn. Controleer details bij de verstrekker. Elk hard feit toont een citaat uit de brontekst.